Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
950.25B | 941.17B | 868.69B | 853.06B | 717.29B | 509.71B | Gross Profit |
341.05B | 354.85B | 306.62B | 302.71B | 285.35B | 217.48B | EBIT |
115.34B | 113.35B | 104.20B | 95.52B | 91.37B | 95.53B | EBITDA |
151.18B | 154.48B | 133.26B | 110.19B | 217.12B | 137.76B | Net Income Common Stockholders |
69.68B | 79.74B | 72.51B | 61.96B | 150.31B | 149.26B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
654.52B | 571.03B | 557.43B | 490.35B | 516.87B | 375.41B | Total Assets |
1.82T | 1.76T | 1.75T | 1.70T | 1.69T | 1.31T | Total Debt |
165.93B | 205.61B | 195.57B | 176.60B | 181.44B | 147.29B | Net Debt |
-129.00B | -42.51B | -30.48B | -48.57B | -173.25B | -195.41B | Total Liabilities |
678.54B | 652.23B | 630.12B | 613.36B | 606.58B | 433.33B | Stockholders Equity |
1.01T | 986.54B | 989.71B | 948.52B | 937.52B | 755.45B |
Cash Flow | Free Cash Flow | ||||
159.36B | 150.51B | 165.40B | 89.44B | 188.60B | 135.22B | Operating Cash Flow |
171.45B | 182.59B | 199.75B | 142.76B | 231.79B | 180.61B | Investing Cash Flow |
-74.57B | -26.07B | -137.10B | -193.76B | -244.39B | -112.42B | Financing Cash Flow |
-99.25B | -108.24B | -64.03B | -69.28B | 30.28B | 75.21B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | HK$2.21T | 16.43 | 11.98% | 0.86% | 3.92% | 27.80% | |
77 Outperform | $4.34T | 20.75 | 21.80% | 0.71% | 6.35% | 68.85% | |
76 Outperform | $1.20T | 46.44 | 13.43% | ― | 32.62% | 32.85% | |
74 Outperform | HK$466.16B | 10.06 | 17.58% | 2.40% | 4.83% | 76.96% | |
73 Outperform | ¥2.07T | 16.74 | 11.97% | 1.68% | 5.85% | 30.65% | |
70 Outperform | $780.07B | 22.64 | 22.07% | ― | 19.90% | ― | |
59 Neutral | $10.74B | 10.21 | -6.69% | 3.04% | 7.44% | -10.92% |